Mukul Agrawal buys 1.21% of Apsis Aerocom as funds sell: at ₹597 the stock is 5.4 times its IPO price and trades at 95x FY26 profit

Mukul Agrawal now holds 1.21% of Apsis Aerocom, a Bengaluru precision-engineering company that listed on NSE Emerge in March. His name appears for the first time in the September-quarter shareholding pattern. In the same six months the funds that came in at the IPO sold most of their shares. The stock closed at ₹596.90 on 9 October. That is 5.4 times its ₹110 issue price. At this price the company is valued at about 95 times the profit it earned in FY26. Does the business support that price?

Apsis Aerocom (NSE Emerge: APSISAERO) - Share price: ₹596.90 (close of 9 October 2026, up 5% on the day; markets were shut on 10 October) - Market cap: ₹719 crore - P/E: about 95x on FY26 profit of ₹7.51 crore, which means investors pay about ₹95 for every ₹1 of yearly profit (Unimech Aerospace, the one peer named in the offer document, is at about 123x, though it is a much bigger and different business) - Book value: ₹40.6 per share, so the price is 14.7 times book value - Range since listing: ₹147.20 to ₹634.00

What the shareholding table shows

The company's September 2026 shareholding pattern lists Mukul Mahavir Agrawal with 1.21%. He is not in the 1%-plus list for March 2026, so he was either absent or below 1% then.

- 1.21% of 1.205 crore shares is about 1.46 lakh shares - At ₹596.90 that is about ₹8.7 crore - The table shows each holder's percentage at the end of the quarter only. It does not say when anyone bought or what they paid. Whatever he paid was inside the ₹147 to ₹634 range the stock has traded in since listing, so his cost could be a quarter of today's price or almost all of it

The same table shows who sold:

Holder type March 2026 September 2026 --------- Promoters 73.02% 73.02% FIIs (foreign funds) 3.02% 0.39% DIIs (Indian funds and insurers) 5.25% 2.73% Public 18.72% 23.87% Number of shareholders 307 521

Funds and insurers together fell by about 5.2 points, roughly 6.2 lakh shares. The public holding rose by the same 5.2 points. The seven anchor investors (large institutions that buy just before an IPO opens) took 9.16 lakh shares, 7.6% of the 1.205 crore shares in issue, so the timing fits anchors selling once their lock-in ended. The table does not prove that, because it does not name sellers or buyers. It also does not show that Mukul Agrawal bought from them. His 1.21% is about a quarter of the size of the shift. The promoters did not sell.

Two other new names are in the 1%-plus list: Ashmavir Financial Consultants (1.96%) and Sanjay Popatlal Jain (1.18%). Two holders from March, Mayuri Shripal Vora and Kashmira Ajay Patel, trimmed from 2.00% to 1.49% and from 1.91% to 1.42%.

What the company does

Apsis Aerocom makes precision-machined parts for aerospace, defence and healthcare customers, to the customer's own drawings. The plant is in the Peenya industrial area of Bengaluru. It was incorporated on 16 August 2022 and listed on NSE Emerge, the SME platform, on 18 March 2026.

- About 100 employees and 15 to 20 customers, according to management - Capacity of 1.2 lakh components a year in FY25, about 82% used, according to the draft offer document. Management says Unit 1 is now fully used - Management says most orders come from foreign equipment makers because of defence offset rules, but about 90% of the parts are delivered inside India, to the Indian armed forces - Management says about 40% of revenue comes from parts where Apsis is the only supplier. This is the company's own claim

The three promoters, as the offer document describes them:

- Basavaraju Kanakatte Shivakumar, managing director, aged about 37. Trained at the Nettur Technical Training Foundation in Bengaluru and worked as a CNC technician and programmer before 2009. He also runs a sole proprietorship, Acuity Engineering - Mihir Kumar Pradhan, chairman and executive director. Diploma in plastics mould technology, about 20 years as an application engineer - Vinod Kumar Mariyappan, whole-time director, aged about 36. Tool and die maker by trade

The promoters hold 73.02%. This article uses the draft offer document (DRHP) filed on 30 September 2025. I could not open the final RHP, so ages and some details are as of that draft.

The numbers: fast sales growth, lower margin

₹ crore, year to 31 March FY23 FY24 FY25 FY26 --------------- Sales 10.37 16.87 20.49 30.65 Operating profit (EBITDA) 1.92 4.17 10.20 11.50 Operating margin 18.5% 24.7% 49.8% 37.5% Profit after tax (PAT) 1.03 2.55 6.60 7.51 Cash from operations 1.29 5.76 0.05 7.04 Borrowings 2.44 2.65 2.76 4.50 Fixed assets 2.90 7.03 7.20 12.32 Total assets 7.22 11.93 17.74 63.18

- Sales rose 50% in FY26 but profit rose only 14% - Management gives three reasons for the lower margin. Unit 2 sat idle but still cost rent, power and staff. Listing and governance costs came in. Raw material costs rose - The second half of FY26 was the best period yet. Sales were ₹16.99 crore, 78% above the same half a year earlier. Profit was ₹4.24 crore, up 42% - The half-year margins were 47% (second half of FY25), 35% (first half of FY26) and 39% (second half of FY26)

Is profit turning into cash? In FY26, yes. Cash from operations was ₹7.04 crore against ₹7.51 crore of profit. In FY25 it was almost nothing (₹0.05 crore against ₹6.60 crore).

- Customers owed about 13% of sales at March 2026, against 18% a year earlier. Management quotes an average collection period of about 45 days. A data site computes 48 days - Management quotes 77 days of stock. The data site computes 151 days. The two use different methods, so treat both with care - A data site computes 173 days of payables, meaning the company takes about that long to pay its suppliers. That lets it hold cash longer, but cash would suffer if suppliers asked for faster payment - Fixed assets were only ₹12.32 crore against ₹63.18 crore of total assets. Most of the rest is cash from the IPO. The business is light on assets today, but the ₹60 crore Unit 2 plan changes that - Borrowings of ₹4.50 crore are small against net worth of about ₹48.9 crore

Defence did the growing, and a few customers pay the bills

Management put FY26 sales at about 65% defence (₹20 crore), 26% aerospace (₹7.85 crore) and 8% healthcare (₹2.36 crore). These add to about ₹30.2 crore of the ₹30.65 crore total; the small rest is other sales and rounding. The draft offer document gave FY25 as defence 45%, aerospace 30% and healthcare 22%.

₹ crore FY25 FY26 --------- Defence 9.29 about 20 Aerospace 6.17 7.85 Healthcare 4.58 2.36

Defence roughly doubled. Healthcare sales fell by about half. The growth came from defence.

Customer concentration is high but falling. The top five customers were 94.6% of FY25 sales. Management says the largest customer fell from 52% to 35% of sales and the top five from 94% to 87% in FY26. Ten customers made up 99% of FY25 sales.

Orders announced since April, from the company's own filings:

Filed Segment Value To be delivered ------------ 7 Apr Aerospace and defence ₹5.00 crore within 15 months 27 Apr Aerospace and defence ₹2.05 crore within 6 months 29 Apr Aerospace and defence ₹1.10 crore within 2 months 7 May Defence ₹7.24 crore within 10 months 27 May Aerospace and defence ₹1.54 crore within 8 months 24 Jul Aerospace and defence ₹0.80 crore ₹0.20 crore by 15 Sep 2026, ₹0.60 crore by 3 May 2027 16 Sep Healthcare ₹4.30 crore within 7 months

The filings do not name the customers. Management's order book at 5 June was ₹40.5 crore, 1.32 times FY26 sales (defence about ₹25 crore, aerospace about ₹12.9 crore).

One thing to know. On 17 June 2026 the NSE's investigation department wrote to the company. It asked for information, documents and clarifications about the announcements the company made on 27, 29 and 30 April about orders and the outcome of a board meeting. The company told shareholders this is a request for information and that it will cooperate. This is a request for information, not a finding of wrongdoing. I found no later update on how it ended. The board meeting of 30 April approved an extraordinary meeting on 26 May to increase managerial remuneration; I did not find the amount.

The IPO, in brief

- Fresh issue of 32.52 lakh shares at ₹110 (price band ₹104 to ₹110), raising ₹35.77 crore. The promoters sold nothing - Open 11 to 13 March 2026. Subscribed about 129 times; 237 times in the non-institutional category and 100 times for retail - Seven anchor investors took 9,15,600 shares at ₹110 on 10 March, about ₹10.07 crore. I could not find their names - Listed on 18 March at ₹153, a 39% premium - The offer document says up to ₹27.02 crore goes to machinery, and the rest to general purposes, capped at the lower of ₹10 crore or 15% of the issue (₹5.37 crore at this issue size). Management now says Unit 2 will cost about ₹60 crore. It has not said how the rest will be paid for. The sources could be profit, cash on hand or loans

What management has promised (its own targets)

These come from the earnings call on 5 June 2026. They are management's forward-looking statements, not facts.

- FY27 sales of about ₹48 crore: about ₹30 crore from Unit 1 and about ₹18 crore from Unit 2, with Unit 2 less than 50% used. That is 57% above FY26 - FY28: Unit 2 adds about ₹60 crore of sales a year on top of Unit 1's roughly ₹30 crore - Unit 2: a new plant at the Hitech Aerospace and Defence Park near Bengaluru airport, about ₹60 crore of investment, 25 machines this year and about 35 by FY28. Machines come from Europe and Japan with delivery times of 6 to 10 months, and the full set is expected by about December. A company filing dated 14 August reports that Unit 2 was inaugurated - Operating margin: 37% to 40% is sustainable - Order book of ₹40.5 crore, to be completed within a year, with a small part in FY28. Pipeline of more than ₹100 crore, with about 30% expected to convert in FY27 - Mix: defence about 60%, aerospace about 30% and about 20% healthcare and others. As spoken these add to 110%, so treat the mix as rough - Unit 3: on spare land, focused on assemblies and other value-added work, possibly another ₹70 crore or more of sales. No cost given yet - Five-year target: about ₹500 crore of sales by 2031 - 250 new components developed in FY26, and more than four new customers added since February

Management has no earlier targets to check, because the June call was its first. The first real test is the half-year result to 30 September, due by 14 November. The company's trading window has been shut since 1 October.

Valuation: expensive, and priced for the plan

- At the ₹110 issue price the company was valued at about ₹133 crore, 17.7 times FY26 profit - At ₹596.90 it is ₹719 crore, about 95 times FY26 profit and 14.7 times book value - Return on equity was 25.5% and ROCE 32.0% in FY26, both lower than the 43% three-year average

The draft offer document names one listed peer, Unimech Aerospace and Manufacturing. Its P/E was about 265 in September 2025. Today it is about 123, with a market cap of ₹8,830 crore, return on equity of 8.0% and ROCE of 11.2%. Being cheaper than Unimech does not make Apsis cheap, because scale, growth and risk differ. Two other listed defence and aerospace names for context: Hindustan Aeronautics at about 33 times and Data Patterns at about 85 times.

An illustration, not a forecast or company guidance. The assumptions are mine. Suppose FY27 sales reach ₹48 crore and the operating (EBITDA) margin is 37.5%. That is about ₹18 crore of operating profit. Take off about ₹2 crore of depreciation and ₹0.5 crore of interest, then 27% tax. Profit is about ₹11.4 crore, and today's market cap is about 63 times that. At the current price, investors already expect the company to meet its targets. If it falls short, the price could come under pressure.

Risks

- Very small and young: sales of ₹30.65 crore, incorporated in 2022, with a market cap 23 times its annual sales. SME shares trade thinly and the IPO lot was 2,400 shares, about ₹14 lakh at today's price - Customer concentration: the top five customers were 87% of FY26 sales, and defence now supplies about 65% - Order disclosure: the filings do not name customers, and the NSE has asked about earlier announcements - Margin: fell from 50% to 38%, and a 37% to 40% margin is unusually high for contract machining - Execution: Unit 2 costs about ₹60 crore, more than twice what the IPO earmarked for machinery, and it started later than planned - Fund selling: funds cut their holding from 8.3% to 3.1% in six months - Half-year reporting: SME companies report twice a year, so news arrives in large blocks

The takeaway Mukul Agrawal's 1.21% tells you he is now a holder, not what he paid or why. The business is growing fast and turns profit into cash, but the stock is now 5.4 times its issue price, a gain of about 443% in seven months, and sells at about 95 times profit. The half-year results due by 14 November will show whether the ₹48 crore plan is on track.

Note: I am not a SEBI-registered investment advisor. This article is for educational purposes only and is not investment advice. Please consult a registered financial advisor before making investment decisions.

Sources

- https://nsearchives.nseindia.com/emerge/corporates/content/Registration30092025233505DRHP.pdf - https://nsearchives.nseindia.com/corporate/APSIS202508062026175813NSEintimationEarningscallTranscript05062026signed.pdf - https://nsearchives.nseindia.com/corporate/APSIS202528052026191810OutcomeofBMFinancialresults31032026Signed.pdf - https://nsearchives.nseindia.com/corporate/APSIS202518062026140506NSEInvestigationdated17062026coveringletter.pdf - https://nsearchives.nseindia.com/corporate/APSIS202530042026161056OutcomeofBoardmeeting30042026signed.pdf - https://nsearchives.nseindia.com/corporate/APSIS202507052026144001DislcosureunderReg30Workorder07052026signed.pdf - https://nsearchives.nseindia.com/corporate/APSIS202516092026122424DislcosureunderReg30Workorder15092026.pdf - https://nsearchives.nseindia.com/corporate/APSIS202507042026131352DislcosureunderReg30Workorder07042026signed.pdf - https://nsearchives.nseindia.com/corporate/APSIS202527042026105927DislcosureunderReg30Workorder25042026Signed.pdf - https://nsearchives.nseindia.com/corporate/APSIS202529042026154155DislcosureunderReg30Workorder29042026signed.pdf - https://nsearchives.nseindia.com/corporate/APSIS202527052026183053DislcosureunderReg30Workorder27052026signed.pdf - https://nsearchives.nseindia.com/corporate/APSIS202524072026143747DislcosureunderReg30Workorder24072026signed.pdf - https://www.5paisa.com/news/apsis-aerocom-ipo-subscription-status - https://hdfcsky.com/news/apsis-aerocom-lists-at-rs-153-on-nse-sme - https://anandrathi.com/stocks/apsis-aerocom-ltd/share-price-today